Category: HHS

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD

Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the New England Compounding Pharmacy made the news in 2012. The facility was filthy, unregulated, and Read more »

Interview with the CEO of Neovasc, Alexei Marko

The Deans of Johns Hopkins and Miami discuss ACO’s

By Steven Greer, MD

Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations, or ACO’s. The new ACA healthcare law will mandate academic medical centers to form new groups of doctors and Read more »

How did a small academic lab succeed where big medical device companies failed?

July 5, 2014- Interviewed by Steven E. Greer, MD

The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas” being developed by engineers at Boston University and medical doctors at Massachusetts General hospital. We interviewed Ed Damiano, PhD, the lead biomedical engineer, and Steven Russell, MD PhD, the lead endocrinologist.

In Part 3, we asked them how their small lab funded only by the NIH succeeded at developing the bionic pancreas when large companies, such as Roche, Medtronic, Abbott, and JNJ all failed.

 

Senator Angus King discusses his bill to make medical device pricing transparent to the public

July 9, 2014- Interviewed by Steven E. Greer, MD

Senator Angus King from Maine has proposed a a bill that would make the pricing of medical devices more transparent. Currently, hospitals are required to sign confidentiality agreements, and the market is entirely in the dark. If such a law were passed, it would turn the medical device industry on its head.

Interview with Dexcom’s CEO Terry Gregg

August 11, 2014- Interviewed by Steven E. Greer, MD

Above, in Part 1 of our interview with the CEO of Dexcom, Terry Gregg, Read more »

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

October 23, 2013- Interviewed by Steven E. Greer, MD

The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer. Topics discussed include the latest clinical trial data on inhaled insulin Afrezza and the cash situation. We also discuss Mr. Mann’s other company, Second Sight, which has a Medicare and FDA-approved bionic eye to treat diseases that damage the nerves in the retina.

Super rapid acting insulin and inhaled insulin

The newly approved Edwards Lifesciences Sapien 3 aortic valve

July 5, 2015- Interviewed by Steven E. Greer, MD

We interviewed William Suh, MD of UCLA about the newly approved Edwards Lifesciences Sapien 3 aortic valve. Read more »

Steven Greer MD: A discussion with Bill O’Reilly about radiation risks

A discussion with Bill O’Reilly about radiation risks from the Fukushima nuclear meltdowns and the fallout hitting the U.S. and entire globe.

Updated: February 28, 2012

A report on the handling of the Fukushima nuclear plant crisis confirmed what Dr. Greer first said last year: that the government and TEPCO were lying to the public and downplaying the risk, while also being incompetent in handling the meltdowns.

The Netflix Late Reviewer: American Sniper missed the mark

TV-screen-with-feetJuly 4, 2015- by Steven E. Greer, MD

I finally saw the acclaimed Clint Eastwood film American Sniper. Bradley Cooper played the character of decorated Navy SEAL sniper Chris Kyle, for which he was nominated Read more »

WordPress Themes

hogan outlet calvin klein baratos calzoncillos calvin klein baratos calzoncillos calvin klein calzoncillos calvin klein ralph lauren canada cheap tiffany calzoncillos calvin klein baratos calvin klein baratos calzoncillos calvin klein calzoncillos calvin klein baratos calzoncillo Calvin Klein hogan outlet online hogan outlet outlet hogan sito ufficiale michael kors uk outlet